About Us Services Careers FAQ Contact Us 0
Home Biotechnology Global Organoids and Spheroids Market Share and Forecast to 2031

Organoids and Spheroids Market Size, Share & Trends Analysis Report By Type (Organoids, Neural Organoids, Hepatic Organoids, Intestinal Organoids), By Spheroids (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres , Embryoid bodies), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity and Efficacy Testing), By End-user (Biotechnology and Pharmaceutical Industries, Academic and Research Institutes, Hospitals and Diagnostic Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRBI1267DR
Author : Straits Research

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Organoids and Spheroids Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Organoids and Spheroids Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. 3D Biomatrix (The U.S.)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. 3D Biotek LLC (The U.S.)
    3. AMS Biotechnology (Europe) Limited (U.K.)
    4. ATCC (The U.S.)
    5. Cellesce Ltd.
    6. Corning Incorporated (The U.S.)
    7. Greiner Bio-One (The U.S.)
    8. Hubrecht Organoid Technology (HUB) (the Netherlands)
    9. Kuraray (Japan)
    10. Lonza (Japan)
    11. Merck KGaA (The U.S.)
    12. Thermo Fisher Scientific, Inc. (The U.S.)
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Get Free Access


We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.